IRLAB Therapeutics AB’s Post

IRLAB today announced that the company’s interim report for the period January-September 2024, has been published. A presentation of the Q3 interim report will be held through a digital webcast on Wednesday, October 30, 2024, at 10.00 CET. The presentation will be held in English, followed by a Q&A session. Access via link: https://lnkd.in/dCdWspDD Read the full report on the IRLAB website: https://lnkd.in/dkr8NADn

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics